New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Cancer Treatments and Research

Cancer Treatments and Research

Learn more about the progress made in improving cancer survival ratesByJulia KnoxUpdated on November 17, 2023Medically reviewed byDoru Paul, MDConsiderable progress has been ma
World medicine November 20,2023
Cancer Treatments and Research

Cancer Treatments and Research

Learn more about the progress made in improving cancer survival ratesByJulia KnoxUpdated on November 17, 2023Medically reviewed byDoru Paul, MDConsiderable progress has been ma
World medicine November 20,2023
Immunotherapy for Cancer: What Are My Options?

Immunotherapy for Cancer: What Are My Options?

ByJennifer WelshPublished on September 06, 2023Medically reviewed byDoru Paul, MDImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immu
Oncology November 20,2023
Immunotherapy for Cancer: What Are My Options?

Immunotherapy for Cancer: What Are My Options?

ByJennifer WelshPublished on September 06, 2023Medically reviewed byDoru Paul, MDImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immu
Oncology November 20,2023
Early MRD Monitoring in Younger Patients With MCL Posttransplant Predicts Outcomes

Early MRD Monitoring in Younger Patients With MCL Posttransplant Predicts Outcomes

December 22, 2020Wayne KuznarDecember 22, 2020 - Minimum residual disease negativity in the bone marrow and peripheral blood prior to autologous stem cell transplant predicts better progression-free s
World medicine November 20,2023
Early MRD Monitoring in Younger Patients With MCL Posttransplant Predicts Outcomes

Early MRD Monitoring in Younger Patients With MCL Posttransplant Predicts Outcomes

December 22, 2020Wayne KuznarDecember 22, 2020 - Minimum residual disease negativity in the bone marrow and peripheral blood prior to autologous stem cell transplant predicts better progression-free s
World medicine November 20,2023
How Does Cancer Actually Kill You?

How Does Cancer Actually Kill You?

ByKrystina WagnerUpdated on August 08, 2023Medically reviewed byGagandeep Brar, MDCancer is not always fatal, but many people do die from the disease. Causes of cancer deaths c
World medicine November 20,2023
How Does Cancer Actually Kill You?

How Does Cancer Actually Kill You?

ByKrystina WagnerUpdated on August 08, 2023Medically reviewed byGagandeep Brar, MDCancer is not always fatal, but many people do die from the disease. Causes of cancer deaths c
World medicine November 20,2023
European Approval Sought for Ibrutinib Plus Bendamustine/Rituximab for Previously Untreated MCL

European Approval Sought for Ibrutinib Plus Bendamustine/Rituximab for Previously Untreated MCL

April 4, 2022Kristi RosaA Type II variation application seeking the approval of a new indication for ibrutinib plus bendamustine and rituximab in adult patients with previously untreated mantle cell l
World medicine November 20,2023
European Approval Sought for Ibrutinib Plus Bendamustine/Rituximab for Previously Untreated MCL

European Approval Sought for Ibrutinib Plus Bendamustine/Rituximab for Previously Untreated MCL

April 4, 2022Kristi RosaA Type II variation application seeking the approval of a new indication for ibrutinib plus bendamustine and rituximab in adult patients with previously untreated mantle cell l
World medicine November 20,2023
Off-the-Shelf NK Immunotherapy With Chemotherapy and Transplant Shows Early Activity in B-Cell NHL

Off-the-Shelf NK Immunotherapy With Chemotherapy and Transplant Shows Early Activity in B-Cell NHL

February 17, 2021Lisa AstorFebruary 17, 2021 — Cord blood–derived natural killer immunotherapy, when paired with high-dose chemotherapy and autologous stem cell transplant, showcased early antitumor a
World medicine November 20,2023
Off-the-Shelf NK Immunotherapy With Chemotherapy and Transplant Shows Early Activity in B-Cell NHL

Off-the-Shelf NK Immunotherapy With Chemotherapy and Transplant Shows Early Activity in B-Cell NHL

February 17, 2021Lisa AstorFebruary 17, 2021 — Cord blood–derived natural killer immunotherapy, when paired with high-dose chemotherapy and autologous stem cell transplant, showcased early antitumor a
World medicine November 20,2023
Allogeneic SCT Benefits Children and Adolescents With Relapsed Anaplastic Large Cell Lymphoma

Allogeneic SCT Benefits Children and Adolescents With Relapsed Anaplastic Large Cell Lymphoma

December 23, 2020Katie KoskoDecember 23, 2020 — Findings from the International, Prospective ALCL-Relapse trial showed that allogeneic SCT after reinduction chemotherapy can lead to survival improveme
World medicine November 20,2023
Allogeneic SCT Benefits Children and Adolescents With Relapsed Anaplastic Large Cell Lymphoma

Allogeneic SCT Benefits Children and Adolescents With Relapsed Anaplastic Large Cell Lymphoma

December 23, 2020Katie KoskoDecember 23, 2020 — Findings from the International, Prospective ALCL-Relapse trial showed that allogeneic SCT after reinduction chemotherapy can lead to survival improveme
World medicine November 20,2023
Stage 4 Non-Small Cell Lung Cancer: Staging, Treatment, Prognosis

Stage 4 Non-Small Cell Lung Cancer: Staging, Treatment, Prognosis

NSCLC is the Most Common Type of Lung CancerByLynne Eldridge, MDUpdated on May 05, 2023Medically reviewed byLindsay Cook, PharmDStage 4non-small cell lung cancer(NS
World medicine November 20,2023
Stage 4 Non-Small Cell Lung Cancer: Staging, Treatment, Prognosis

Stage 4 Non-Small Cell Lung Cancer: Staging, Treatment, Prognosis

NSCLC is the Most Common Type of Lung CancerByLynne Eldridge, MDUpdated on May 05, 2023Medically reviewed byLindsay Cook, PharmDStage 4non-small cell lung cancer(NS
World medicine November 20,2023
Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice

Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice

April 23, 2021Heather Buschman, PhDStudy supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multip
World medicine November 20,2023
Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice

Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice

April 23, 2021Heather Buschman, PhDStudy supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multip
World medicine November 20,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com